Partner at Novo Holdings
View Live Interactive Profile →Raymond Camahort is a Partner in Novo Holdings' Venture Investments team, based with Novo Holdings US Inc. Novo Holdings says he has over 15 years of combined investment, business and research experience with expertise in biochemistry, genetics and gene therapy or editing. Before joining Novo Ventures he worked in business development at the Harvard University Office of Technology Development, helping commercialise technologies from the chemistry and stem cell and regenerative biology departments. He completed a National Institutes of Health post-doctoral training fellowship at Harvard University and was a pre-doctoral fellow at the Stowers Institute for Medical Research. His Novo Holdings page states that he has served on the boards of Ray Therapeutics, Arcellx, Inspirna, iECURE, Riva Therapeutics and OnCusp Therapeutics; because the page uses the past perfect and does not say which seats are current, no board seats are recorded here. He holds a PhD in biochemistry and molecular biology from the University of Kansas and a BS in biological sciences from UC Santa Barbara.